Skip to main content
Fig. 1 | Trials

Fig. 1

From: Outcome pre-specification requires sufficient detail to guard against outcome switching in clinical trials: a case study

Fig. 1

Results for different outcome definitions of further bleeding in TRIGGER. *Outcome definitions: (1) recurrent bleeding only, in hospital, assessed via direct visual inspection; (2) recurrent bleeding only, up to day 28, assessed via direct visual inspection; (3) recurrent bleeding only, in hospital, assessed via clinical judgement or direct visual inspection; (4) recurrent and persistent bleeding, up to day 28, assessed via direct visual inspection; (5) recurrent and persistent bleeding, in hospital, assessed via direct visual inspection; (6) recurrent bleeding only, up to day 28, assessed via clinical judgement or direct visual inspection; (7) recurrent and persistent bleeding, up to day 28, assessed via clinical judgement or direct visual inspection; (8) recurrent and persistent bleeding, in hospital, assessed via clinical judgement or direct visual inspection

Back to article page